Clover Corporation Limited · ASX:CLV

Clover — H1 2015 Earnings Presentation

13 slides from Clover's earnings presentation, Mar 25, 2015

  1. Slide 1: 6 months to 31 Jan 2015

    For personal use only 6 months to 31 Jan 2015 25 March 2015

  2. Slide 2: Vision and Mission Statement

    For personal use only VISION AND MISSION STATEMENT Vision: To optimise the health and development of adults, infants and children. Mission: To deliver science based bioactives which provide health benefits to the global infant, infant children, children adult and medical food markets. 2

  3. Slide 3: Half Year 2015 Results

    Half Year 2015 Results For personal use only AUD million 4D Reported 4D Reported 31 Jan 2015 31 Jan 2014 Revenue $16.1 $14.9 Profit before tax $0.9 $1.9 EBITDA $1.1 $2.0 EBIT $0.9 $1.8 Tax ($0.2) ($0.5) NPAT $0.7 $1.4 EPS 0.43 cps 0.83 cps 3

  4. Slide 4: Balance Sheet January 2015

    Balance Sheet For personal use only 31 January 2015 AUD million Reported Reported Movement 31 Jan 2015 31 Jul 2014 2.2È Cash $5 8 $5.8 $8 0 $8.0 0.9È Trade Receivables $7.2 $8.1 0È Inventories $15.5 $16.5 1.0 3.4È Total Current Assets $29.5 $32.9 0.1È PPE/Intangible Assets $4.8 $4.9 3.9È Total Asset

  5. Slide 5: Cash Flow

    Cash Flow For personal use only 6 months ended 31 Jan 2015 AUD million Reported From Operations 31 Jan 2015 EBITDA $1.1 Working Capital Movement ($2.9) Tax Received $0 5 $0.5 Cash Flow from Operations ($1.3) Financing Activities ($0.8) Capex ($0.1) Net Cash Flow ($2.2) 5

  6. Slide 6: 1H 2015 Key Items

    For personal use only 1H 2015 KEY ITEMS • Revenue improved 6% driven by growth of customers in existing and new markets. • Revenue from China based customers has not improved as quickly as we would like. • Profit down 47.8% impacted by a change in customer ordering preference, raw material cost incr

  7. Slide 7: Delivery Systems Based on a Variety of Nutritional Bioactives

    DELIVERY SYSTEMS BASED ON A VARIETY OF NUTRITIONAL BIOACTIVES For personal use only • Product portfolio includes Sales Revenue based on encapsulated powders containing Diversified Bioactives in 1H 2015 marine i oil,il algal l l oils, il other th specialty oils and important micronutrients • Encapsul

  8. Slide 8: Sales by Geography/Product

    SALES BY GEOGRAPHY/PRODUCT For personal use only 1H 2015 Geographic • Continued strong presence though Oceania and Asia Australia / New Zealand 44% Asia 41% • Encapsulation technology strong and proven Europe 9% Americas 6% 1H 2015 Products Oil 2% Encapsulated Powders 98% 8

  9. Slide 9: Growth Objectives

    For personal use only GROWTH OBJECTIVES Focus on New Products Development of i f t formula infant f l and dPProcess M di l F Medical Foods d customers and Development Program market • Partnering of • Enhancement of • Clinical trial of customers in existing products preterm product. expansion and and

  10. Slide 10: Operational Objectives

    For personal use only OPERATIONAL OBJECTIVES Supply Chain Clover and Nu- Employee security it andd M Mega brand b d d development l t integration development and engagement • Contingency plans to • Brand • Developing a team cover all supply chain development and culture and requirements. positioning

  11. Slide 11: Full Year 2015 Outlook & Priorities

    FULL YEAR 2015 OUTLOOK & For personal use only PRIORITIES • Strengthen our sales team to develop new customer and market opportunities. • Focus on our existing customers to grow with them in products, applications and markets. • Maintain focus on efficiencies in operational expenditure and inventory

  12. Slide 12: Thank You

    For personal use only THANK YOU Questions? 12

  13. Slide 13: Disclaimer

    For personal use only DISCLAIMER The release, publication or distribution of this presentation in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which this presentation is released, published or distributed should inform themselves about and observe s

Clover — H1 2015 Earnings Presentation on 6ix